Holen Sie sich die Stockscreener-App
1.52
3.80%
-0.06
Vorhandelsmarkt:
1.51
-0.01
-0.66%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTXR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.58
Offen:
$1.57
24-Stunden-Volumen:
267.89K
Relative Volume:
0.37
Marktkapitalisierung:
$25.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-39.14M
KGV:
-0.2546
EPS:
-5.97
Netto-Cashflow:
$-28.20M
1W Leistung:
-5.88%
1M Leistung:
+10.95%
6M Leistung:
+97.66%
1J Leistung:
-83.06%
1-Tages-Spanne:
$1.47
$1.60
1-Wochen-Bereich:
$1.47
$1.67
52-Wochen-Spanne:
$0.65
$12.84
Citius Pharmaceuticals Inc Stock (CTXR) Company Profile
Firmenname
Citius Pharmaceuticals Inc
Sektor
Branche
Telefon
(908) 967-6676
Adresse
11 COMMERCE DRIVE, CRANFORD, NJ
Vergleichen Sie CTXR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTXR
Citius Pharmaceuticals Inc
|
1.52 | 29.19M | 0 | -39.14M | -28.20M | -5.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-30 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2021-11-30 | Eingeleitet | Maxim Group | Buy |
Citius Pharmaceuticals Inc Aktie (CTXR) Neueste Nachrichten
How Citius Pharmaceuticals Inc. (47N0) stock reacts to new regulationsEntry Point & Entry Point Confirmation Alerts - newser.com
Why Citius Pharmaceuticals Inc. stock could rally in 2025July 2025 Final Week & Reliable Momentum Entry Alerts - newser.com
How Citius Pharmaceuticals Inc. (47N0) stock moves in volatile trading sessions2025 Historical Comparison & Reliable Intraday Trade Plans - newser.com
Applying Elliott Wave Theory to Citius Pharmaceuticals Inc.Bull Run & Risk Managed Trade Strategies - newser.com
Is Citius Pharmaceuticals Inc. (47N0) stock undervalued at current price2025 Momentum Check & Reliable Intraday Trade Plans - newser.com
Is Citius Pharmaceuticals Inc. (47N0) stock a contrarian opportunityJuly 2025 Catalysts & Capital Efficiency Focused Strategies - newser.com
Is Citius Pharmaceuticals Inc. stock attractive for passive investors - newser.com
Citius Pharmaceuticals Inc. stock chart pattern explained2025 Volatility Report & Safe Capital Growth Stock Tips - newser.com
Is Citius Pharmaceuticals Inc. stock positioned for long term growth2025 Key Lessons & Reliable Breakout Forecasts - newser.com
Is Citius Pharmaceuticals Inc. (47N0) stock in buy zone after pullback2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
Full technical analysis of Citius Pharmaceuticals Inc. stockWeekly Investment Report & Weekly Hot Stock Watchlists - newser.com
Is Citius Pharmaceuticals Inc. stock a buy before product launchesIndex Update & Fast Exit/Entry Strategy Plans - newser.com
Can a trend reversal in Citius Pharmaceuticals Inc. lead to recoveryJuly 2025 Drop Watch & Accurate Buy Signal Alerts - newser.com
What Wall Street predicts for Citius Pharmaceuticals Inc. stock priceOil Prices & High Yield Stock Recommendations - newser.com
Why Citius Pharmaceuticals Inc. stock could outperform in 20252025 Retail Activity & AI Forecasted Stock Moves - newser.com
Is Citius Pharmaceuticals Inc. (47N0) stock considered safe havenMarket Volume Report & Weekly High Momentum Picks - newser.com
Should you wait for a breakout in Citius Pharmaceuticals Inc.Market Risk Report & Safe Entry Momentum Stock Tips - newser.com
Can Citius Pharmaceuticals Inc. stock sustain market leadershipStop Loss & Fast Momentum Entry Tips - newser.com
What MACD and RSI say about Citius Pharmaceuticals Inc.Weekly Trend Report & Accurate Intraday Trading Signals - newser.com
Has Citius Pharmaceuticals Inc. found a price floor2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com
Heatmap analysis for Citius Pharmaceuticals Inc. and competitors2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
Finanzdaten der Citius Pharmaceuticals Inc-Aktie (CTXR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):